Buy KBL Merger Corp. IV Units 2017-15.01.2024 Cons of 1 Sh + 1 Wt 01.24 Stock | KBLMU Stock Price & Latest News | Public.com
KBLMU

KBL Merger Corp. IV Units 2017-15.01.2024 Cons of 1 Sh + 1 Wt 01.24

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View KBL Merger Corp. IV Units 2017-15.01.2024 Cons of 1 Sh + 1 Wt 01.24 (KBLMU) stock trends here

    About KBLMU

    180 Life Sciences Corp. develops pharmaceuticals for chronic pain and inflammatory diseases. It operates as a clinical-stage biotechnology company focused on the development of novel drugs that fulfil unmet needs in inflammatory diseases, fibrosis and pain by leveraging...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    Stats

    Market Cap$45,01M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$14.52
    1 Year Low$7.62
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app